Palantir's $1.3 Billion Defense Deal Sets Stage for Volatile Earnings

Palantir's Maven system becomes a Pentagon Program of Record in a $1.3B deal, boosting shares ahead of critical Q1 2026 earnings. Analysts are divided on its high valuation.

A major U.S. Department of Defense contract has provided a fresh catalyst for Palantir Technologies' stock, just weeks before a critical quarterly report. The Pentagon is accelerating the integration of Palantir's Maven Smart System into its long-term budget planning, securing the software firm a place in the Army's official "Program of Record." This move locks in a framework agreement worth nearly $1.3 billion through 2029.

The news helped lift the shares to €122.52, pushing them precisely to the 50-day moving average at €122.39. This marks a weekly gain of almost 10%, offering some respite in a challenging year. Since January, the stock has shed roughly 16% of its value and currently trades about 33% below its 52-week high of €179.86.

Wall Street's view of the company remains sharply divided. While the defense win attracts institutional buyers like KBC Group, which increased its stake by 11.1% to approximately 712,000 shares, analysts are recalibrating their models. On April 14, Mizuho analyst Gregg Moskowitz trimmed his price target from $195 to $185, though he maintained an "Outperform" rating. He cited a need to reassess valuation premiums in the AI software sector ahead of earnings, not a doubt in Palantir's growth trajectory. Mizuho currently prefers Cloudflare, ServiceNow, and Atlassian as top picks for the reporting season.

In contrast, Wedbush labels Palantir a central player in the AI revolution and issues a $230 price target. Prominent skeptics like Michael Burry, however, warn of rising competition from new AI providers such as Anthropic.

All attention now turns to May 4, 2026, when Palantir releases its first-quarter results. The company has set a high bar, guiding for Q1 revenue between $1.532 billion and $1.536 billion and an adjusted operating income of $870 to $874 million. For the full year 2026, management forecasts revenue of approximately $7.19 billion, implying growth of about 61%.

The fundamental story is powerful. In Q4 2025, revenue surged 70% year-over-year to $1.4 billion, marking a tenth consecutive quarter of accelerating growth. U.S. commercial revenue skyrocketed 137%. The core issue is valuation. Even after its pullback, the stock trades at about 99 times its expected 2026 earnings, a stark contrast to the sector median of around 21.

The upcoming report will be decisive. A clean beat on guidance could validate the growth narrative, while even a slight miss risks extending the stock's yearly decline. With 33 daily moves exceeding 5% in the past twelve months, a Relative Strength Index reading of 67.5, and annualized volatility over 52%, a quiet run-up to May 4 is unlikely. The 200-day moving average, sitting at €141.62, looms well above the current price as a reminder of the technical ground that needs to be recovered.